{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:50:59Z","timestamp":1781769059540,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":921,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.bbmt.2012.04.011","type":"journal-article","created":{"date-parts":[[2012,4,21]],"date-time":"2012-04-21T18:41:05Z","timestamp":1335033665000},"page":"1589-1599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Incidence and Risk Factors for Early Hepatotoxicity and Its Impact on Survival in Patients with Myelofibrosis Undergoing Allogeneic Hematopoietic Cell Transplantation"],"prefix":"10.1016","volume":"18","author":[{"given":"Kit Man","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eshetu G.","family":"Atenafu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kuruvilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey H.","family":"Lipton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Messner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2012.04.011_bib1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/MOH.0b013e3283257ab2","article-title":"Allogeneic hematopoietic cell transplantation for patients with myelofibrosis","volume":"16","author":"Zang","year":"2009","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.bbmt.2012.04.011_bib2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/bmt.2009.56","article-title":"Severe hepatocellular injury after hematopoietic cell transplant: incidence, etiology and outcome","volume":"44","author":"Sakai","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.04.011_bib3","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/00042737-200412000-00019","article-title":"Liver disease is a major cause of mortality following allogeneic bone marrow transplantation","volume":"16","author":"El-Sayed","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.bbmt.2012.04.011_bib4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.bmt.1702453","article-title":"Liver disease during the first post-transplant year in bone marrow transplantation recipients: retrospective study","volume":"26","author":"Kim","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.04.011_bib5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00042737-200402000-00006","article-title":"Abnormal liver function tests following bone marrow transplantation: aetiology and role of liver biopsy","volume":"16","author":"Ho","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.bbmt.2012.04.011_bib6","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1001\/archinte.1973.00320100060007","article-title":"Gastrointestinal and abdominal manifestations of agnogenic myeloid metaplasia","volume":"131","author":"Silverstein","year":"1973","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.bbmt.2012.04.011_bib7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0609.1978.tb02497.x","article-title":"Nature and incidence of liver involvement in agnogenic myeloid metaplasia","volume":"21","author":"Ligumski","year":"1978","journal-title":"Scand J Haematol"},{"key":"10.1016\/j.bbmt.2012.04.011_bib8","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.3748\/wjg.15.3128","article-title":"Portal hypertension secondary to myelofibrosis with myeloid metaplasia: a study of 13 cases","volume":"15","author":"Abu-Hilal","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bbmt.2012.04.011_bib9","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1046\/j.1365-2141.1999.01262.x","article-title":"The Italian Consensus Conference on diagnostic criteria for myelofibrosis with myeloid metaplasia","volume":"104","author":"Barosi","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2012.04.011_bib10","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s12185-010-0529-5","article-title":"Classification and diagnosis of myeloproliferative neoplasms according to the 2008 World Health Organization criteria","volume":"91","author":"Wadleigh","year":"2010","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2012.04.011_bib11","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: working definitions","volume":"15","author":"Bacigalupo","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.04.011_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bbmt.2011.05.022","article-title":"A prospective study comparing the outcomes and health-related quality of life in adult patients with myeloid malignancies undergoing allogeneic transplantation using myeloablative or reduced-intensity conditioning","volume":"18","author":"Gupta","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.04.011_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.leukres.2010.07.015","article-title":"What are RBC transfusion dependence and independence?","volume":"35","author":"Gale","year":"2011","journal-title":"Leuk Res"},{"key":"10.1016\/j.bbmt.2012.04.011_bib14","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2009-09-245837","article-title":"A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the International Working Group for Myeloproliferative Neoplasms Research and Treatment","volume":"115","author":"Passamonti","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.04.011_bib15","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.04.011_bib16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.7326\/0003-4819-144-6-200603210-00007","article-title":"A risk score for mortality after allogeneic hematopoietic cell transplantation","volume":"144","author":"Parimon","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2012.04.011_bib17","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","article-title":"Regimen-related toxicity in patients undergoing bone marrow transplantation","volume":"6","author":"Bearman","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2012.04.011_bib18","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","article-title":"Venoocclusive disease of the liver following bone marrow transplantation","volume":"44","author":"Jones","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2012.04.011_bib19","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.bbmt.2010.02.009","article-title":"Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial","volume":"16","author":"Richardson","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.04.011_bib20","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/hep.1840120515","article-title":"Hepatic vascular disease and portal hypertension in polycythemia vera and agnogenic myeloid metaplasia: a clinicopathological study of 145 patients examined at autopsy","volume":"12","author":"Wanless","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.bbmt.2012.04.011_bib21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1182\/blood.V53.3.515.515","article-title":"Splenectomy in myeloid metaplasia","volume":"53","author":"Silverstein","year":"1979","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.04.011_bib22","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/0002-9343(62)90165-1","article-title":"Portal hypertension in the myeloproliferative syndrome and the reticuloses","volume":"32","author":"Shaldon","year":"1962","journal-title":"Am J Med"},{"key":"10.1016\/j.bbmt.2012.04.011_bib23","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1111\/j.1572-0241.2005.50374.x","article-title":"Portal hypertension secondary to myelofibrosis: a study of three cases","volume":"100","author":"Alvarez-Larran","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bbmt.2012.04.011_bib24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2169\/internalmedicine.46.1768","article-title":"Transjugular intrahepatic portosystemic shunt for the treatment of portal hypertension due to idiopathic myelofibrosis","volume":"46","author":"Doki","year":"2007","journal-title":"Intern Med"},{"key":"10.1016\/j.bbmt.2012.04.011_bib25","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/hep.1840170214","article-title":"Portal hypertension in lymphoproliferative and myeloproliferative disorders: hemodynamic and histological correlations","volume":"17","author":"Dubois","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.bbmt.2012.04.011_bib26","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/0016-5085(87)90984-X","article-title":"Agnogenic myeloid metaplasia, portal hypertension, and sinusoidal abnormalities","volume":"92","author":"Roux","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbmt.2012.04.011_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/sj.leu.2404048","article-title":"Frequency and risk factors for thrombosis in idiopathic myelofibrosis: analysis in a series of 155 patients from a single institution","volume":"20","author":"Cervantes","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2012.04.011_bib28","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1182\/blood-2009-08-238956","article-title":"Thrombosis in primary myelofibrosis: incidence and risk factors","volume":"115","author":"Barbui","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.04.011_bib29","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jhep.2010.07.004","article-title":"Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension?","volume":"53","author":"Thabut","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.bbmt.2012.04.011_bib30","series-title":"Vascular Liver Disease: Mechanisms and Management","first-page":"51","article-title":"Stellate cells and the microcirculation","author":"Pinzani","year":"2011"},{"key":"10.1016\/j.bbmt.2012.04.011_bib31","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1600-0609.2007.00842.x","article-title":"Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity\/mortality","volume":"78","author":"Takatoku","year":"2007","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.bbmt.2012.04.011_bib32","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1002\/hep.23533","article-title":"Hepatobiliary complications of hematopoietic cell transplantation, 40 years on","volume":"51","author":"McDonald","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bbmt.2012.04.011_bib33","first-page":"655","article-title":"Laparoscopic liver biopsy to evaluate hepatic dysfunction in patients with hematologic malignancies: a useful tool to effect changes in management","volume":"17","author":"Iqbal","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.04.011_bib34","first-page":"63","article-title":"Iron overload and liver dysfunction after allogeneic or autologous bone marrow transplantation","volume":"17","author":"McKay","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.04.011_bib35","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbmt.2006.01.004","article-title":"Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"12","author":"Kamble","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.04.011_bib36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/sj.bmt.1705899","article-title":"Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies","volume":"41","author":"Ho","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.04.011_bib37","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/hep.20529","article-title":"Serum bilirubin levels and mortality after myeloablative allogeneic hematopoietic cell transplantation","volume":"41","author":"Gooley","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.bbmt.2012.04.011_bib38","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1182\/blood-2003-04-1311","article-title":"Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients","volume":"103","author":"Hogan","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.04.011_bib39","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bbmt.2004.01.002","article-title":"Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation","volume":"10","author":"Chalandon","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.04.011_bib40","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/pbc.21425","article-title":"Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children","volume":"50","author":"Qureshi","year":"2008","journal-title":"Pediatr Blood Cancer"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879112001619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879112001619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:42:07Z","timestamp":1761057727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879112001619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S1083879112001619"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2012.04.011","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and Risk Factors for Early Hepatotoxicity and Its Impact on Survival in Patients with Myelofibrosis Undergoing Allogeneic Hematopoietic Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2012.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}